Zacks Research Issues Optimistic Outlook for ENSG Earnings

Key Points

• Zacks Research raised its earnings estimates for The Ensign Group. The firm now forecasts $1.73 in Q3 2026 EPS and lifted its FY2026, FY2027, and FY2028 estimates to $6.98, $7.26, and $8.19, respectively.
• Ensign recently beat quarterly expectations, reporting $1.92 EPS versus the $1.80 consensus, while revenue increased 16.7% year over year to $1.44 billion. Analysts maintain a consensus “Moderate Buy” rating with a $216.25 target price.
• Potential securities-law investigations introduce risk. Law firms are examining allegations that Ensign may have issued misleading business information, though the notices do not establish wrongdoing.

The Ensign Group, Inc. (NASDAQ:ENSG - Free Report) - Stock analysts at Zacks Research upped their Q3 2026 earnings estimates for shares of The Ensign Group in a research report issued to clients and investors on Tuesday, September 1st. Zacks Research analyst Team now forecasts that the company will earn $1.73 per share for the quarter, up from their previous estimate of $1.70. The consensus estimate for The Ensign Group's current full-year earnings is $6.93 per share. Zacks Research also issued estimates for The Ensign Group's Q4 2026 earnings at $1.86 EPS, FY2026 earnings at $6.98 EPS, Q1 2027 earnings at $1.79 EPS, Q2 2027 earnings at $1.69 EPS, Q3 2027 earnings at $1.94 EPS, Q4 2027 earnings at $1.83 EPS, FY2027 earnings at $7.26 EPS, Q1 2028 earnings at $2.02 EPS, Q2 2028 earnings at $1.86 EPS and FY2028 earnings at $8.19 EPS.

The Ensign Group (NASDAQ:ENSG - Get Free Report) last released its earnings results on Monday, July 27th. The company reported $1.92 earnings per share for the quarter, topping analysts' consensus estimates of $1.80 by $0.12. The business had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.44 billion. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The business's revenue was up 16.7% on a year-over-year basis. During the same period last year, the company posted $1.59 EPS. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS.

A number of other equities analysts also recently commented on ENSG. Wall Street Zen downgraded The Ensign Group from a "buy" rating to a "hold" rating in a research report on Saturday, July 25th. Weiss Ratings cut The Ensign Group from a "buy (b)" rating to a "buy (b-)" rating in a report on Tuesday, June 16th. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $228.00 target price on shares of The Ensign Group in a research note on Tuesday, July 28th. Finally, Truist Financial lifted their price target on The Ensign Group from $202.00 to $207.00 and gave the stock a "hold" rating in a report on Thursday, July 30th. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $216.25.

The Ensign Group Price Performance

ENSG stock opened at $172.09 on Friday. The Ensign Group has a 1 year low of $141.58 and a 1 year high of $218.00. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.21 and a quick ratio of 1.21. The firm has a market capitalization of $10.03 billion, a PE ratio of 26.97, a price-to-earnings-growth ratio of 1.66 and a beta of 0.69. The business has a 50 day simple moving average of $174.30 and a 200-day simple moving average of $183.03.

Institutional Investors Weigh In On The Ensign Group

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ENSG. California State Teachers Retirement System lifted its stake in shares of The Ensign Group by 15,582.5% in the 2nd quarter. California State Teachers Retirement System now owns 10,563,449 shares of the company's stock valued at $1,693,321,000 after purchasing an additional 10,496,091 shares during the last quarter. BlackRock Inc. acquired a new stake in shares of The Ensign Group during the 2nd quarter worth about $937,218,000. Wasatch Advisors LP increased its position in shares of The Ensign Group by 6.0% during the 2nd quarter. Wasatch Advisors LP now owns 3,558,675 shares of the company's stock worth $548,961,000 after purchasing an additional 199,983 shares during the last quarter. Geode Capital Management LLC raised its holdings in The Ensign Group by 3.4% in the 4th quarter. Geode Capital Management LLC now owns 1,498,673 shares of the company's stock valued at $261,107,000 after buying an additional 49,117 shares during the period. Finally, Price T Rowe Associates Inc. MD raised its holdings in The Ensign Group by 9.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,332,505 shares of the company's stock valued at $232,124,000 after buying an additional 118,110 shares during the period. Institutional investors and hedge funds own 96.12% of the company's stock.

Insider Activity at The Ensign Group

In related news, Director John Agwunobi sold 392 shares of the company's stock in a transaction that occurred on Monday, July 20th. The stock was sold at an average price of $171.06, for a total value of $67,055.52. Following the transaction, the director directly owned 9,503 shares in the company, valued at approximately $1,625,583.18. This represents a 3.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 4.00% of the company's stock.

The Ensign Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th were issued a dividend of $0.065 per share. The ex-dividend date was Tuesday, June 30th. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.2%. The Ensign Group's dividend payout ratio (DPR) is currently 4.08%.

Key Headlines Impacting The Ensign Group

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: Zacks Research raised earnings forecasts across multiple periods. The firm lifted its estimates for Q3 and Q4 2026, full-year 2026, several 2027 quarters, full-year 2027, and 2028. Its FY2026 EPS forecast increased to $6.98 from $6.77, FY2027 to $7.26 from $7.06, and FY2028 to $8.19 from $7.89. The revisions imply improving expectations for Ensign’s earnings trajectory and are above the current full-year consensus estimate of $6.93.
• Positive Sentiment: Ensign’s operating model continues to show potential for organic growth. A Zacks analysis highlighted higher occupancy, improved clinical results, and stronger productivity across facilities, suggesting growth may extend beyond acquisitions. Can Ensign Group's Operating Model Drive Growth Beyond Acquisitions?
• Neutral Sentiment: The company previously reported quarterly EPS of $1.92, ahead of the $1.80 analyst estimate, while revenue rose 16.7% year over year to $1.44 billion. However, the shares remain below their 200-day moving average, indicating that broader valuation and momentum concerns may limit the immediate benefit from the higher forecasts.
• Negative Sentiment: Multiple law firms are investigating possible securities-law violations. Rosen Law Firm and Kaplan Fox say they are examining allegations that Ensign may have issued materially misleading business information. The notices do not establish wrongdoing, but they introduce potential litigation costs, uncertainty, and reputational risk for shareholders. Rosen Law Firm Securities Class Action Investigation Kaplan Fox Securities Law Investigation

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company's model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source